These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32887985)

  • 1. Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia: Beauty Remains in the Eye of the Beholder.
    Karchmer AW
    Clin Infect Dis; 2021 May; 72(9):1526-1528. PubMed ID: 32887985
    [No Abstract]   [Full Text] [Related]  

  • 2. Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial.
    Pujol M; Miró JM; Shaw E; Aguado JM; San-Juan R; Puig-Asensio M; Pigrau C; Calbo E; Montejo M; Rodriguez-Álvarez R; Garcia-Pais MJ; Pintado V; Escudero-Sánchez R; Lopez-Contreras J; Morata L; Montero M; Andrés M; Pasquau J; Arenas MD; Padilla B; Murillas J; Jover-Sáenz A; López-Cortes LE; García-Pardo G; Gasch O; Videla S; Hereu P; Tebé C; Pallarès N; Sanllorente M; Domínguez MÁ; Càmara J; Ferrer A; Padullés A; Cuervo G; Carratalà J;
    Clin Infect Dis; 2021 May; 72(9):1517-1525. PubMed ID: 32725216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.
    del Río A; Gasch O; Moreno A; Peña C; Cuquet J; Soy D; Mestres CA; Suárez C; Pare JC; Tubau F; Garcia de la Mària C; Marco F; Carratalà J; Gatell JM; Gudiol F; Miró JM;
    Clin Infect Dis; 2014 Oct; 59(8):1105-12. PubMed ID: 25048851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
    Holubar M; Meng L; Deresinski S
    Infect Dis Clin North Am; 2016 Jun; 30(2):491-507. PubMed ID: 27208769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
    García-de-la-Mària C; Gasch O; García-Gonzalez J; Soy D; Shaw E; Ambrosioni J; Almela M; Pericàs JM; Tellez A; Falces C; Hernandez-Meneses M; Sandoval E; Quintana E; Vidal B; Tolosana JM; Fuster D; Llopis J; Pujol M; Moreno A; Marco F; Miró JM
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS; McDermott BP; Cunha BA
    Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: the potential role of daptomycin.
    Bamberger DM
    Ther Clin Risk Manag; 2007 Aug; 3(4):675-84. PubMed ID: 18472990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity, mortality, and management of methicillin-resistant S. aureus bacteremia in the USA: update on antibacterial choices and understanding.
    Ortwine JK; Bhavan K
    Hosp Pract (1995); 2018 Apr; 46(2):64-72. PubMed ID: 29400119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.
    Shaw E; Miró JM; Puig-Asensio M; Pigrau C; Barcenilla F; Murillas J; Garcia-Pardo G; Espejo E; Padilla B; Garcia-Reyne A; Pasquau J; Rodriguez-Baño J; López-Contreras J; Montero M; de la Calle C; Pintado V; Calbo E; Gasch O; Montejo M; Salavert M; Garcia-Pais MJ; Carratalà J; Pujol M; ; ;
    BMJ Open; 2015 Mar; 5(3):e006723. PubMed ID: 25762232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.
    Dhand A; Sakoulas G
    Clin Ther; 2014 Oct; 36(10):1303-16. PubMed ID: 25444563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin.
    Cunha BA; Krol V; Kodali V
    Heart Lung; 2008; 37(1):72-5. PubMed ID: 18206530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Higher Daptomycin Dose (7 mg/kg or Greater) with Improved Survival in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Timbrook TT; Caffrey AR; Luther MK; Lopes V; LaPlante KL
    Pharmacotherapy; 2018 Feb; 38(2):189-196. PubMed ID: 29235661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
    J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
    Bhavnani SM; Prakhya A; Hammel JP; Ambrose PG
    Clin Infect Dis; 2009 Sep; 49(5):691-8. PubMed ID: 19635023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients.
    Ji S; Jiang S; Wei X; Sun L; Wang H; Zhao F; Chen Y; Yu Y
    J Infect Dis; 2020 Mar; 221(Suppl 2):S243-S252. PubMed ID: 32176794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Geriak M; Haddad F; Rizvi K; Rose W; Kullar R; LaPlante K; Yu M; Vasina L; Ouellette K; Zervos M; Nizet V; Sakoulas G
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH
    Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
    Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
    Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.